Search research articles
Contact Us
Filters
Showing results (151-160 of 328) with videos related to
Page
of 33
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
September 28, 2016
Imaging and Clinical Profile Following Concurrent Stereotactic Radiation and Immune Therapy for Melanoma Brain Metastases: Preliminary Results
C Shen, D D M Lin, K J Redmond, et al.
British Journal of Haematology
|
January 6, 2016
Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era
Loretta J Nastoupil, Rajni Sinha, Michelle Byrtek, et al.
Cancer
|
March 22, 2012
Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study
Chadi Nabhan, Michelle Byrtek, Michael D Taylor, et al.
Blood
|
October 8, 2015
Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy
Eric M Ammann, Michael P Jones, Brian K Link, et al.
American Journal of Hematology
|
April 7, 2017
Associations between elevated pre-treatment serum cytokines and peripheral blood cellular markers of immunosuppression in patients with lymphoma
Moritz Binder, Megan M O'Byrne, Matthew J Maurer, et al.
British Journal of Haematology
|
April 9, 2015
Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States
Chadi Nabhan, Michelle Byrtek, Ashish Rai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2000
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment
T A Davis, A J Grillo-López, C A White, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2021
Impact of Organ Function-Based Clinical Trial Eligibility Criteria in Patients With Diffuse Large B-Cell Lymphoma: Who Gets Left Behind?
Arushi Khurana, Raphael Mwangi, Grzegorz S Nowakowski, et al.
American Journal of Hematology
|
July 19, 2017
Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose-adjusted EPOCH plus rituximab
Mary-Kate Malecek, Adam M Petrich, Shaina Rozell, et al.
Leukemia & Lymphoma
|
September 30, 2014
Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States
Loretta J Nastoupil, Rajni Sinha, Michelle Byrtek, et al.
Page
of 33
Search research articles
Search
Showing results (151-160 of 328) with videos related to
Sort By:
Page
of 33
International Journal of Radiation Oncology, Biology, Physics
|
September 28, 2016
Imaging and Clinical Profile Following Concurrent Stereotactic Radiation and Immune Therapy for Melanoma Brain Metastases: Preliminary Results
C Shen, D D M Lin, K J Redmond, et al.
British Journal of Haematology
|
January 6, 2016
Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era
Loretta J Nastoupil, Rajni Sinha, Michelle Byrtek, et al.
Cancer
|
March 22, 2012
Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study
Chadi Nabhan, Michelle Byrtek, Michael D Taylor, et al.
Blood
|
October 8, 2015
Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy
Eric M Ammann, Michael P Jones, Brian K Link, et al.
American Journal of Hematology
|
April 7, 2017
Associations between elevated pre-treatment serum cytokines and peripheral blood cellular markers of immunosuppression in patients with lymphoma
Moritz Binder, Megan M O'Byrne, Matthew J Maurer, et al.
British Journal of Haematology
|
April 9, 2015
Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States
Chadi Nabhan, Michelle Byrtek, Ashish Rai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2000
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment
T A Davis, A J Grillo-López, C A White, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2021
Impact of Organ Function-Based Clinical Trial Eligibility Criteria in Patients With Diffuse Large B-Cell Lymphoma: Who Gets Left Behind?
Arushi Khurana, Raphael Mwangi, Grzegorz S Nowakowski, et al.
American Journal of Hematology
|
July 19, 2017
Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose-adjusted EPOCH plus rituximab
Mary-Kate Malecek, Adam M Petrich, Shaina Rozell, et al.
Leukemia & Lymphoma
|
September 30, 2014
Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States
Loretta J Nastoupil, Rajni Sinha, Michelle Byrtek, et al.
Page
of 33